Disease Info Card

Hypermobility Syndrome

Information about Hypermobility Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hypermobility Syndrome

Most recent studies have shown that Hypermobility Syndrome shares some biological mechanisms with anxiety-disorders, arthralgia, arthritis, arthropathy, back-pain, blepharoptosis, connective-tissue-diseases, degenerative-polyarthritis, dislocations, ehlers-danlos-syndrome, ehlers-danlos-syndrome-type-3-(disorder), fibromyalgia, hernia, joint-laxity, marfan-syndrome, marfanoid-joint-hypermobility-syndrome, mitral-valve-prolapse-syndrome, pain, rheumatism, rheumatoid-arthritis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hypermobility Syndrome, and have been seen in publications frequently: Aging, Coagulation, Defecation, Gastric Emptying, Hemostasis, Lactation, Pathogenesis, Platelet Aggregation, Proprioception, Reflex

Quite a number of genes have been found to play important roles in Hypermobility Syndrome, such as ARSA, BEST1, BLM, COL1A2, COL3A1, COMP, CTSC, DMD, GP1BB, IGF1, IL1RAPL2, IRF1, NRK, RHO, RHOD, SLC14A1, TBX4, TNXB. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.